Humacyte Inc (HUMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 20,571 | 93,563 | 115,505 | 80,448 | 99,986 |
| TOTAL | $23,005 | $96,110 | $117,926 | $83,278 | $102,851 |
| Non-Current Assets | |||||
| PPE Net | 24,250 | 24,820 | 25,653 | 26,791 | 27,851 |
| Other Non-Current Assets | 67,509 | 17,351 | 17,887 | 18,154 | 18,683 |
| TOTAL | $91,759 | $42,171 | $43,540 | $44,945 | $46,534 |
| Total Assets | $114,764 | $138,281 | $161,466 | $128,223 | $149,385 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,903 | 6,005 | 3,452 | 6,490 | 3,018 |
| Accrued Expenses | 11,151 | 8,950 | 7,917 | 9,340 | 9,586 |
| TOTAL | $20,942 | $17,757 | $14,087 | $18,443 | $15,137 |
| Non-Current Liabilities | |||||
| aiOther Non-Current Liabilities | 143,164 | 133,688 | 105,377 | 79,941 | 80,295 |
| TOTAL | $157,543 | $148,811 | $121,227 | $96,234 | $97,255 |
| Total Liabilities | $178,485 | $166,568 | $135,314 | $114,677 | $112,392 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 125,860 | 119,351 | 119,084 | 119,084 | 103,575 |
| Common Shares | 12 | 12 | 12 | 10 | 10 |
| Retained earnings | -665,075 | -625,873 | -569,210 | -537,314 | -512,208 |
| TOTAL | $-63,721 | $-28,287 | $26,152 | $13,546 | $36,993 |
| Total Liabilities And Equity | $114,764 | $138,281 | $161,466 | $128,223 | $149,385 |